Axsome Therapeutics, Inc. Annual Costs and Expenses in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Axsome Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2020 to 2023.
  • Axsome Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $167M, a 39.6% increase year-over-year.
  • Axsome Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $645M, a 54.6% increase year-over-year.
  • Axsome Therapeutics, Inc. annual Costs and Expenses for 2023 was $502M, a 119% increase from 2022.
  • Axsome Therapeutics, Inc. annual Costs and Expenses for 2022 was $230M, a 84.3% increase from 2021.
  • Axsome Therapeutics, Inc. annual Costs and Expenses for 2021 was $125M, a 25.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $502M +$273M +119% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 $230M +$105M +84.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $125M +$25.6M +25.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-23
2020 $99.1M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.